0HRV37Z
Replacement Breast, Bilateral to No Qualifier with Autologous Tissue Substitute, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | H Skin and Breast |
| Operation | R Replacement |
| Body Part | V Breast, Bilateral |
| Approach | 3 Percutaneous |
| Device | 7 Autologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically takes the place and/or function of all or a portion of a body part
Procedure Overview
Replacement procedures in the skin and breast involve putting in material, biological or synthetic, that physically takes over for tissue that has been removed or is absent. The clearest example is breast implant placement following mastectomy, where a saline or silicone implant substitutes for the breast tissue that was removed. Skin grafting for extensive wounds or burns, where donor or synthetic skin substitutes for tissue that cannot heal on its own, also falls into this family.
These procedures are performed when tissue loss is too extensive for simple repair, or when a body part such as the breast has been surgically removed and the patient elects reconstruction. The replacement material can come from the patient's own body, a donor, or be entirely synthetic, and it is meant to remain in place, unlike a temporary dressing or expander used only to stretch skin.
Timing varies considerably: some replacements happen in the same operation as the tissue removal, known as immediate reconstruction, while others are staged over months, especially when tissue expanders are used first to prepare the site before the permanent implant or flap is placed.
Anatomy & Axis Detail
Breast, Bilateral
Bilateral breast replacement is coded when both breasts undergo simultaneous placement of prosthetic or other substitute material, typically following bilateral mastectomy for cancer treatment, prophylactic risk reduction in high-risk patients, or bilateral exchange of previously placed implants. Performing the procedure bilaterally allows the surgeon to match implant size, projection, and pocket placement between sides for symmetry in a single operative session, which can simplify planning compared to staged unilateral procedures. Considerations include the condition of the chest wall and skin envelope on each side independently, since prior radiation or differing amounts of native tissue can necessitate different implant choices even though the procedure is bilateral. Documentation should confirm that both breasts were addressed in the same operative episode to support coding this as a single bilateral body part value rather than two separate procedures.
Approach: Percutaneous
Percutaneous describes entry by needle or instrument puncture through the skin or mucous membrane to reach the site of the procedure, without cutting the tissue open or using a visualizing scope. It differs from Open in that the site itself is never exposed, and from Percutaneous Endoscopic in that no endoscope is used to see internal structures. Common examples include needle biopsies and injections.
Device: Autologous Tissue Substitute
Autologous Tissue Substitute identifies a device value where material harvested from the patient's own body, such as an autograft, is used to replace or reconstruct a body part. Its defining feature is tissue origin from the patient, setting it apart from Nonautologous Tissue Substitute, sourced from a donor or animal, and Synthetic Substitute, made of manufactured material.
Coding & Documentation
Coders need the operative report to specify the material used, since the qualifier distinguishes autologous tissue from synthetic or nonautologous substitutes, and this materially changes the code selected. Documentation must also make clear that the replaced body part or region is anatomically taking the place of what was removed, not simply reinforcing existing tissue.
A frequent mistake is coding Replacement when a tissue expander, a temporary device meant to be removed later, was placed rather than a permanent implant; expander insertion is typically coded as Insertion, not Replacement. Coders also sometimes miss that a two-stage breast reconstruction requires separate codes at each encounter, one for expander insertion and later for expander removal with implant replacement. Confusion also arises between an implant placed directly after mastectomy versus one placed as a delayed procedure much later, which does not change the root operation but affects timing and history documentation coders should note.